FACTANKER · measured, cited, anchored official records connected

iBio, Inc. — Revenue by Fiscal Year

16 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/dce23517-5ac3-4afa-8892-3e7e03ee7323/serie/revenue

Fiscal yearRevenuePeriodEvidence
FY 2026$100.0k2025-07-01 – 2026-06-30evidence 0001420720-26-000020
FY 2025$400.0k2024-07-01 – 2025-06-30evidence 0001558370-25-011888
FY 2024$225.0k2023-07-01 – 2024-06-30evidence 0001420720-24-000038
FY 2023$02022-07-01 – 2023-06-30evidence 0001558370-24-000934
FY 2022$1.9M2021-07-01 – 2022-06-30evidence 0001420720-23-000045
FY 2021$2.4M2020-07-01 – 2021-06-30evidence 0001558370-21-012819
FY 2020$1.6M2019-07-01 – 2020-06-30evidence 0001558370-21-012819
FY 2019$2.0M2018-07-01 – 2019-06-30evidence 0001144204-19-041659
FY 2018$44.0k2017-07-01 – 2018-06-30evidence 0001144204-19-041659
FY 2017$394.0k2016-07-01 – 2017-06-30evidence 0001144204-18-049866
FY 2016$948.0k2015-07-01 – 2016-06-30evidence 0001144204-16-127993
FY 2015$1.9M2014-07-01 – 2015-06-30evidence 0001144204-15-059224
FY 2014$205.0k2013-07-01 – 2014-06-30evidence 0001144204-14-058454
FY 2013$1.0M2012-07-01 – 2013-06-30evidence 0001144204-13-053105
FY 2012$1.3M2011-07-01 – 2012-06-30evidence 0001144204-13-053105
FY 2011$520.1k2010-07-01 – 2011-06-30evidence 0000930413-12-005739
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

iBio, Inc. — all facts · Net Income · Operating Income